** Shares of radiology center operator RadNet RDNT.O fall 2% to $52 in extended trading
** RDNT says it is acquiring iCAD ICAD.O, an AI breast cancer detection software maker, in an all-stock acquisition valued about $103 million
** RDNT is offering $3.61/shr of ICAD common stock, representing a significant 87% premium to ICAD's closing price on Tuesday
** Shares of iCAD up 73% at $3.31 in extended trading
** Deal expected to close in the second or third quarter of 2025
** RDNT says the deal is expected to add over 1,500 healthcare-provider locations across 50 countries to its network
** As of last close, RDNT down 24% and ICAD up 5.5%, YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。